| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0278-5846(03)00043-5 |
| P698 | PubMed publication ID | 12691788 |
| P50 | author | Alessandro Serretti | Q56380923 |
| P2093 | author name string | Chi-Un Pae | |
| Soo-Jung Lee | |||
| Chul Lee | |||
| Jung-Jin Kim | |||
| Chang-Uk Lee | |||
| In-Ho Paik | |||
| Soo Yang | |||
| Ho-Ran Park | |||
| P2860 | cites work | A simple salting out procedure for extracting DNA from human nucleated cells | Q27861086 |
| Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia | Q28291484 | ||
| Differential and region-specific activation of mitogen-activated protein kinases following chronic administration of phencyclidine in rat brain | Q31884094 | ||
| Redox mechanisms at the glutamate synapse and their significance: a review | Q33633204 | ||
| Apoptosis and schizophrenia: is the tumour suppressor gene, p53, a candidate susceptibility gene? | Q33870188 | ||
| Use of unlinked genetic markers to detect population stratification in association studies. | Q34390859 | ||
| Oxidative nerve cell death in Alzheimer's disease and stroke: antioxidants as neuroprotective compounds | Q34658945 | ||
| Glutathione transferases as markers of preneoplasia and neoplasia | Q38655792 | ||
| Molecular psychiatry. Adaptations of receptor-coupled signal transduction pathways underlying stress- and drug-induced neural plasticity. | Q40649194 | ||
| Programmed cell death: implications for neuropsychiatric disorders | Q40699849 | ||
| Induction of reactive oxygen species in neurons by haloperidol. | Q41012302 | ||
| Recent advances in defining the neuropathology of schizophrenia | Q41166037 | ||
| Free radical pathology in schizophrenia: a review | Q41185166 | ||
| Genetic linkage analysis of schizophrenia using chromosome 11q13-24 markers in Israeli pedigrees | Q41652983 | ||
| Ebselen attenuates oxidative stress-induced apoptosis via the inhibition of the c-Jun N-terminal kinase and activator protein-1 signalling pathway in PC12 cells | Q42149374 | ||
| Glutathione S-transferase Pi is a dopamine-inducible suppressor of dopamine-induced apoptosis in PC12 cells | Q43627951 | ||
| The dopamine agonist cabergoline provides neuroprotection by activation of the glutathione system and scavenging free radicals | Q44053425 | ||
| Linkage map of eight human chromosome 11q markers, including DRD2, spanning 60 cM | Q45035212 | ||
| Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia | Q48660056 | ||
| Characterization of hydrogen peroxide toxicity in cultured rat forebrain neurons. | Q48792928 | ||
| Automated image analysis of disturbed cytoarchitecture in Brodmann area 10 in schizophrenia: a post-mortem study. | Q49131119 | ||
| Glutathione-S-transferase in the ageing rat brain cerebrum and the effect of chlorpromazine | Q49161799 | ||
| Reduced status of plasma total antioxidant capacity in schizophrenia. | Q50872362 | ||
| Abnormal age-related changes of plasma antioxidant proteins in schizophrenia. | Q51070794 | ||
| On the functional of neuromelanin. | Q67409450 | ||
| Reliability and validity of the positive and negative syndrome scale for schizophrenics | Q68335911 | ||
| A prospective follow-up study of brain morphology and cognition in first-episode schizophrenic patients: preliminary findings | Q70862901 | ||
| Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer | Q73248663 | ||
| Processing of Alzheimer's amyloid precursor protein during H2O2-induced apoptosis in human neuronal cells | Q73475838 | ||
| Association of brain structural change with the heterogeneous course of schizophrenia from early childhood through five years subsequent to a first hospitalization | Q73531877 | ||
| Human plasma glutathione peroxidase and symptom severity in schizophrenia | Q77836919 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 519-523 | |
| P577 | publication date | 2003-05-01 | |
| P1433 | published in | Progress in Neuro-Psychopharmacology & Biological Psychiatry | Q15616665 |
| P1476 | title | Association study between glutathione S-transferase P1 polymorphism and schizophrenia in the Korean population | |
| P478 | volume | 27 |
| Q47288324 | Analysis of glutathione S-transferase genes polymorphisms and the risk of schizophrenia in a sample of Iranian population |
| Q89939326 | Association Between Glutathione S-Transferase (GST) Polymorphisms and Schizophrenia in a Chinese Han Population |
| Q84626296 | Bipolar disorder and polymorphisms of glutathione S-transferases M1 (GSTM1) and T1 (GSTT1) |
| Q35173614 | Genetic Association Studies of Antioxidant Pathway Genes and Schizophrenia |
| Q26795761 | Genetic Polymorphisms of Glutathione-Related Enzymes (GSTM1, GSTT1, and GSTP1) and Schizophrenia Risk: A Meta-Analysis |
| Q41771204 | Glutathione S-Transferase Deletion Polymorphisms in Early-Onset Psychotic and Bipolar Disorders: A Case-Control Study |
| Q92258255 | Glutathione Transferase P1-1 an Enzyme Useful in Biomedicine and as Biomarker in Clinical Practice and in Environmental Pollution |
| Q35015897 | Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene |
Search more.